Xcout Intel
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Subscribe to see Dewpoint Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dewpoint Therapeutics, Inc. at a glance
Dewpoint Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $346M across the 4 funding rounds on record. Its most recent funding round raised $77.2M in September 2025. Xcout tracks 18 named people at Dewpoint Therapeutics, Inc., including Ameet Nathwani (President and Chief Executive Officer).
Dewpoint Therapeutics, Inc. leadership
- Ameet NathwaniPresident and Chief Executive Officer
- Ameet Nathwani, M.D.Executive Officer
- Elisabeth A. LeidermanExecutive Officer
- Elisabeth LeidermanExecutive Officer
- Isaac A. Klein, M.D., Ph.D.Executive Officer
- Lori A. EscobedoExecutive Officer
12 more named people on record for Dewpoint Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Dewpoint Therapeutics, Inc. funding rounds
At least $346M raised across the 4 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $77.2M | — | |
| Series C | $150M | 14 named | |
| Series B | $77M | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Dewpoint Therapeutics, Inc. news
- FundingPrivate placement (Form D)
Investors
Dewpoint Therapeutics, Inc. competitors
A few of Dewpoint Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools, and automation to discover novel small molecules.
Peptone is a biotechnology research company headquartered in London, England. The firm is developing a product engine to generate small-molecule drug candidates aimed at intrinsically disordered proteins.
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Get Dewpoint Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dewpoint Therapeutics, Inc. in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access